The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wang, Changli ^a   Su, Yanjun ^a   Zhang, Lianmin ^a   Wang, Meng ^a   You, Jian ^a   Zhao, Xiaoliang ^a   Zhang, Zhenfa ^a   Liu, Jun ^a   Hao, Xishan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; SUPPRESOR OF AP 1 REGULATED BY INTERFERON PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; WNT PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; VIMENTIN;

EID: 84866844176     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038046     Document Type: Article

References (33)

1. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, et al. (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465: 473-477.
2. Feldser DM, Kostova KK, Winslow MM, Taylor SE, Cashman C, et al. (2010) Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature 468: 572-575.
3. Kyprianou N, (2010) ASK-ing EMT not to spread cancer. Proc Natl Acad Sci U S A 107: 2731-2732.
4. Asnaghi L, Vass WC, Quadri R, Day PM, Qian X, et al. (2010) E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases. Oncogene 29: 2760-2771.
5. Kim AN, Jeon WK, Lim KH, Lee HY, Kim WJ, et al. (2011) Fyn mediates transforming growth factor-beta1-induced down-regulation of E-cadherin in human A549 lung cancer cells. Biochem Biophys Res Commun 407: 181-184.
6. Kook EH, Kim YM, Kim HT, Koh JS, Choi YJ, et al. (2010) Prognostic value of E-cadherin expression in non-small cell lung cancer treated with gefitinib. Oncol Res 18: 445-451.
7. Osada H, Tomida S, Yatabe Y, Tatematsu Y, Takeuchi T, et al. (2008) Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 68: 1647-1655.
8. Tseng RC, Lee SH, Hsu HS, Chen BH, Tsai WC, et al. (2010) SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res 70: 543-551.
9. Nozawa N, Hashimoto S, Nakashima Y, Matsuo Y, Koga T, et al. (2006) Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma. Pathol Res Pract 202: 639-650.
10. Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J, et al. (2011) Transforming growth factor-beta1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition. Mol Cell Biochem 355: 309-314.
11. Dash R, Su ZZ, Lee SG, Azab B, Boukerche H, et al. (2010) Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1. Oncogene 29: 4412-4423.
12. Su ZZ, Lee SG, Emdad L, Lebdeva IV, Gupta P, et al. (2008) Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc Natl Acad Sci U S A 105: 20906-20911.
13. Braun J, Hoang-Vu C, Dralle H, Huttelmaier S, (2010) Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 29: 4237-4244.
14. Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, et al. (2010) TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol 12: 286-293.
15. Kupferman ME, Jiffar T, El-Naggar A, Yilmaz T, Zhou G, et al. (2010) TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29: 2047-2059.
16. Maschler S, Gebeshuber CA, Wiedemann EM, Alacakaptan M, Schreiber M, et al. (2010) Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med 2: 401-414.
17. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, et al. (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30: 1436-1448.
18. Welsh GI, Proud CG, (1993) Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294 (Pt 3): 625-629.
19. Strand A, Kvernberg K, A MK, Liaaen-Jensen S, (2000) Geometrical E/Z isomers of (6R)- and (6S)-neoxanthin and biological implications. Biochem Syst Ecol 28: 443-455.
20. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, et al. (2005) Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 24: 1571-1583.
21. Cheon SS, Nadesan P, Poon R, Alman BA, (2004) Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res 293: 267-274.
22. Holnthoner W, Pillinger M, Groger M, Wolff K, Ashton AW, et al. (2002) Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem 277: 45847-45853.
23. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, et al. (2005) Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell 19: 159-170.
24. Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, et al. (2006) Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int J Cancer 118: 290-301.
25. Li J, Zhou BP, (2011) Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 11: 49.
26. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, et al. (2003) Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163: 847-857.
27. Hata A, Katakami N, Yoshioka H, Fujita S, Kunimasa K, et al. (2011) Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection. Lung Cancer.
28. Longo F, Riquelme A, Rodriguez M, Olmedo ME, Garrido P, (2011) Long-term survival in a smoking caucasian male patient treated with gefitinib for spinal cord compression secondary to lung cancer. Onkologie 34: 326-328.
29. Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, et al. (2011) How do patient and hospital features influence outcomes in small-cell lung cancer in England? Br J Cancer 105: 746-752.
30. Weng JH, Lee JK, Wu MF, Shen CY, Kao PF, (2011) Pituitary FDG uptake in a patient of lung cancer with bilateral adrenal metastases causing adrenal cortical insufficiency. Clin Nucl Med 36: 731-732.
31. DiMeo TA, Anderson K, Phadke P, Fan C, Perou CM, et al. (2009) A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 69: 5364-5373.
32. Lemjabbar-Alaoui H, Dasari V, Sidhu SS, Mengistab A, Finkbeiner W, et al. (2006) Wnt and Hedgehog are critical mediators of cigarette smoke-induced lung cancer. PLoS One 1: e93.
33. Teng Y, Wang X, Wang Y, Ma D, (2010) Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun 392: 373-379.